Literature DB >> 12917160

Glaucoma and survival: the National Health Interview Survey 1986-1994.

David J Lee1, Orlando Gómez-Marín, Byron L Lam, D Diane Zheng.   

Abstract

OBJECTIVE: Associations between glaucoma and survival have not been studied extensively, in part, because of the relatively low prevalence of this condition. This study examines associations between self-reported glaucoma and mortality in a nationally representative sample of U.S. adults.
DESIGN: Annual cross-sectional multistage area probability survey of the U.S. civilian noninstitutionalized population living at addressed dwellings. PARTICIPANTS: Mortality linkage with >96% of participants from the 1986 to 1994 National Health Interview Survey was performed by the National Center for Health Statistics through 1997. Complete data were available on 116796 adults >or=018 years old.
METHODS: Adults within randomly selected households were administered a chronic conditions list that included questions about glaucoma and visual impairment. Proxy information on these conditions was obtained when household members were unavailable for interview. Statistical methods included Cox regression models with adjustments for covariates, as well as for the complex sample survey design. MAIN OUTCOME MEASURE: All-cause mortality and cardiovascular and cancer mortality.
RESULTS: A total of 1559 (1.3%) glaucoma cases were reported. Nearly 19% of participants with reported glaucoma also had reported visual impairment (n = 303). Mortality linkage identified 8949 deaths; the average follow-up was 7.0 years. After controlling for survey design, gender, age, race, marital status, education level, and self-rated health, participants with reported glaucoma but without reported visual impairment were at significantly increased risk of death relative to participants without reported glaucoma, irrespective of visual impairment status (hazard ratio [HR], 1.35; 95% confidence interval [CI], 1.19-1.53); similar associations were found for participants with reported glaucoma and visual impairment vs. participants with no reported glaucoma (HR, 1.39; 95% CI, 1.14-1.71). An increased risk of cardiovascular disease mortality was found for participants with reported glaucoma both without (HR, 1.31; 95% CI, 1.11-1.55) and with (HR, 1.53; 95% CI, 1.15-2.05) reported visual impairment. Risk of mortality due to cancer was increased only in participants with reported glaucoma but without reported visual impairment (HR, 1.57; 95% CI, 1.25-1.98); this association was stronger when the mortality analysis was restricted to cancers amenable to early screening, including breast, cervical, colon, and prostate cancer (HR, 1.99; 95% CI, 1.41-2.81).
CONCLUSIONS: Among adults residing in the United States, reported glaucoma is associated with an increased risk of all-cause and cardiovascular disease mortality. Associations between glaucoma and cancer were inconsistent and may reflect, in part, a detection bias, in which glaucoma is more likely to be diagnosed in adults receiving health care because of other medical conditions.

Entities:  

Mesh:

Year:  2003        PMID: 12917160     DOI: 10.1016/S0161-6420(03)00408-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

1.  Increased mortality risk among the visually impaired: the roles of mental well-being and preventive care practices.

Authors:  D Diane Zheng; Sharon L Christ; Byron L Lam; Kristopher L Arheart; Anat Galor; David J Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-14       Impact factor: 4.799

2.  Non-standard vision measures predict mortality in elders: the Smith-Kettlewell Institute (SKI) study.

Authors:  Lori A Lott; Marilyn E Schneck; Gunilla Haegerström-Portnoy; John A Brabyn
Journal:  Ophthalmic Epidemiol       Date:  2010-08       Impact factor: 1.648

Review 3.  [PEX syndrome. Clinical diagnosis and systemic manifestations].

Authors:  E Scharfenberg; U Schlötzer-Schrehardt
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

4.  Visual acuity and increased mortality: the role of allostatic load and functional status.

Authors:  D Diane Zheng; Sharon L Christ; Byron L Lam; Stacey L Tannenbaum; Christine L Bokman; Kristopher L Arheart; Laura A McClure; Cristina A Fernandez; David J Lee
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-07-24       Impact factor: 4.799

5.  Longitudinal relationships among visual acuity, daily functional status, and mortality: the Salisbury Eye Evaluation Study.

Authors:  Sharon L Christ; D Diane Zheng; Bonnielin K Swenor; Byron L Lam; Sheila K West; Stacey L Tannenbaum; Beatriz E Muñoz; David J Lee
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

6.  The impact of change in visual field on health-related quality of life the los angeles latino eye study.

Authors:  Cecilia M Patino; Rohit Varma; Stanley P Azen; David V Conti; Michael B Nichol; Roberta McKean-Cowdin
Journal:  Ophthalmology       Date:  2011-03-31       Impact factor: 12.079

7.  Ten-year outcomes in newly diagnosed glaucoma patients: mortality and visual function.

Authors:  Tarun Sharma; John F Salmon
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

8.  Reported visual impairment and risk of suicide: the 1986-1996 national health interview surveys.

Authors:  Byron L Lam; Sharon L Christ; David J Lee; D Diane Zheng; Kristopher L Arheart
Journal:  Arch Ophthalmol       Date:  2008-07

9.  Levels of plasma homocysteine in pseudoexfoliation glaucoma.

Authors:  Laura Tranchina; Marco Centofanti; Francesco Oddone; Lucia Tanga; Gloria Roberti; Laura Liberatoscioli; Claudio Cortese; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-26       Impact factor: 3.117

10.  Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data.

Authors:  Aimee Teo Broman; Harry A Quigley; Sheila K West; Joanne Katz; Beatriz Munoz; Karen Bandeen-Roche; James M Tielsch; David S Friedman; Jonathan Crowston; Hugh R Taylor; Rohit Varma; M Cristina Leske; Boel Bengtsson; Anders Heijl; Mingguang He; Paul J Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.